RT Journal Article
SR Electronic
T1 584 Phase I/II study to evaluate the safety and tolerability of avelumab in combination with other anti-cancer therapies in patients with advanced malignancies
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A664
OP A664
DO 10.1136/jitc-2023-SITC2023.0584
VO 11
IS Suppl 1
A1 Ahmed, Jibran
A1 Knisely, Anne
A1 Stephen, Bettzy
A1 Yang, Yali
A1 Song, Juhee
A1 Alshawa, Anas
A1 Zarifa, Abdulrazzak
A1 Morris, Van
A1 Javle, Milind
A1 Wolff, Robert A
A1 Meric-Bernstam, Funda
A1 Pant, Shubham
A1 Rodon, Jordi
A1 Naing, Aung
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A664.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.